We are excited to announce that we are extending the capabilities of our contactless patient monitoring platform, Oxevision, having received FDA and EU clearances for new sleep monitoring software. This represents a major milestone in our ongoing mission to transform inpatient mental health care.
Our sleep monitoring software leverages physiological and activity data captured by Oxevision’s contactless infrared-sensitive camera to assess patients’ sleep patterns and provide automated daily reports. With accuracy levels comparable to the gold standard in sleep monitoring, polysomnography, this new module empowers healthcare staff to make more informed clinical decisions – promoting better outcomes and recovery.
Todd Haedrich, CEO of Oxehealth: “We are excited to announce our latest world-first breakthrough. We are now actively seeking acute mental health providers, who are forward thinking and interested in leveraging technology to advance their capabilities, to join our new Innovator Program.”
Learn more about the Oxehealth Innovator Program here
